Myovant Sciences's earnings per share without non-recurring items for the
three
months ended in Jun. 2022 was $-0.22.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2022 was $-1.76.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Myovant Sciences's EPS without NRI or its related term are showing as below:
MYOV'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -25.6 Med: -5.5 Max: 18.4
Current: 18.4
MYOV's 3-Year EPS without NRI Growth Rate is ranked better than 62.55% of 1151
companies
in the Biotechnology industry
Industry Median: 7.50
vs MYOV: 18.40
Myovant Sciences's EPS (Diluted) for the
three
months ended in Jun. 2022 was $-0.22.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $-1.76.
Myovant Sciences's EPS (Basic) for the
three
months ended in Jun. 2022 was $-0.22.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2022 was $-1.76.
Myovant Sciences EPS without NRI Historical Data
The historical data trend for Myovant Sciences's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Myovant Sciences Annual Data
Trend
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
EPS without NRI
-2.41
-4.09
-3.37
-2.83
-2.22
Myovant Sciences Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
EPS without NRI
-0.67
-0.23
-0.68
-0.63
-0.22
Competitive Comparison
For the Biotechnology subindustry, Myovant Sciences's EPS without NRI, along with its competitors' market caps and EPS without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Myovant Sciences EPS without NRI Distribution
For the Biotechnology industry and Healthcare sector, Myovant Sciences's EPS without NRI distribution charts can be found below:
* The bar in red indicates where Myovant Sciences's EPS without NRI falls into.
Myovant Sciences EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock. In calculating earnings per share without non-recurring items, the dividends of preferred stocks and Non Operating Income need to subtracted from the total net income first.
EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.76
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Myovant Sciences (NYSE:MYOV) EPS without NRI Explanation
A Non Operating Income refers to an entry that appears on a company's financial statements that is unlikely to happen again. It represents a one-time expense involving an unpredictable event and is not part of a firm's normal, day-to-day operations.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Myovant Sciences EPS without NRI Related Terms
Thank you for viewing the detailed overview of Myovant Sciences's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.
Myovant Sciences Ltd is a healthcare company focused on redefining care for women and for men. The company's lead product candidate is relugolix, a once-daily, oral GnRH receptor antagonist. It has three late-stage clinical programs for relugolix in uterine fibroids, endometriosis, and prostate cancer. The company is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, that has completed a Phase 2a study for the treatment of female infertility as part of assisted reproduction.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.79(4.46%) Volume: 905,404 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:MYOV has been successfully added to your 
